| Health / Medical Topics |
Integrin Receptor Antagonist GLPG0187
A small molecule integrin receptor antagonist (IRA) with potential antineoplastic activity. Upon administration, GLPG0187 binds to and blocks the activity of 5 RGD-integrin receptor subtypes, including alphavbeta1, alphavbeta3, alphavbeta5, alphavbeta6 and alpha5beta1. This may result in the inhibition of endothelial cell-cell interactions and endothelial cell-matrix interactions, and the prevention of angiogenesis and metastasis in tumor cells expressing these integrin receptors. Integrin receptors are transmembrane glycoproteins expressed on the surface of tumor vessel endothelial cells and some types of cancer cells, and play a crucial role in endothelial cell adhesion and migration. (NCI Thesaurus)
YOU MAY ALSO LIKE
Integrin Inhibition involves interference with, or restraint of, the activities of a family of noncovalent heterodimeric transmembrane glycoprotein signal transduction receptors for…
A process that involves the binding of an integrin to one of its ligands, including fibronectin, vitronectin, collagen and laminin. These interactions…
Integrin beta-7 (798 aa, ~87 kDa) is encoded by the human ITGB7 gene. This protein plays a role in both cell adhesion…
Integrin beta-5 (799 aa, ~88 kDa) is encoded by the human ITGB5 gene. This type I membrane protein forms a heterodimer with…
Integrin beta-4 (1822 aa, 202 kD) is a cell adhesion process protein that is encoded by the human ITGB4 gene and has…
Integrin beta-3 (788 aa, 87 kD) is a cell adhesion process protein that is encoded by the human ITGB3 gene and has…
